Buxbaum, J. N. (2012). Evaluation of tafamidis as first-line therapeutic agent for transthyretin familial amyloidotic polyneuropathy. Degener Neurol Neuromuscul Dis.
Chicago Style aipamenaBuxbaum, Joel N. "Evaluation of Tafamidis As First-line Therapeutic Agent for Transthyretin Familial Amyloidotic Polyneuropathy." Degener Neurol Neuromuscul Dis 2012.
MLA aipamenaBuxbaum, Joel N. "Evaluation of Tafamidis As First-line Therapeutic Agent for Transthyretin Familial Amyloidotic Polyneuropathy." Degener Neurol Neuromuscul Dis 2012.
Kontuz: berrikusi erreferentzia hauek erabili aurretik.